Pure papillary serous tumors of the endometrium a clinicopathological analysis of 61 cases from a single institution

International Journal of Gynecological Cancer

Volumn 19, Issue 8, 2009, Pages 1364-1369

  Benito, Virginia ^a   Lubrano, Amina ^a   Arencibia, Octavio ^a   Álvarez, Eva Elisa ^a   León, Laureano ^a   Medina, Norberto ^a   Falcón, Juan Miguel ^a   Falcó N, Orlando ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

Endometrial carcinoma; Ovarian carcinoma; Pure papillary serous tumor

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PAPILLARY CARCINOMA; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; CYSTADENOCARCINOMA, SEROUS; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 73349141383     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181b7a1d5     Document Type: Article

References (27)

1. Hamilton CA, Cheung MK, Ossan K, et al. Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers. Br J Cancer. 2006;94:642-646.
2. Hendrickson M, Ross J, Eifel P, et al. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol. 1982;6:93-108.
3. Hamilton CA, Kapp DS, Chan JK. Clinical aspects of uterine papillary serous carcinoma. Curr Opin Obstet Gynecol. 2008;20:26-33.
4. Carcangiu ML, Chambers JT. Uterine papillary serous carcinoma: a study of 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma. Gynecol Oncol. 1992;47:298-305.
5. Goff BA, Kato D Schmitdt RA, et al. Uterine papillary serous carcinoma: patterns of metastatic spread. Gynecol Oncol. 1994;54: 264-268.
6. Gehrig PA, Groben PA, Fowler WC, et al. Noninvasive papillary serous carcinoma of the endometrium. Obstet Gynecol. 2001;97:153-157.
7. O'Halan KA, Levine PA, Harbatkin D, et al. Virulence of papillary endometrial carcinoma. Gynecol Oncol. 1990;37:112-119.
8. Hendrickson M, Ross J, Eifel PJ, et al. Adenocarcinoma of the endometrium: analysis of 256 cases with carcinoma limited to the uterine corpus. Gynecol Oncol. 1982;13:373-392.
9. Slomovitz BM, Burke TW, Eifel PJ, et al. Uterine papillary serous carcinoma: a single institution review of 129 cases. Gynecol Oncol. 2003;91:463-469.
10. Goldberg H, Miller RC, Abdah-Bortnyah R, et al. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network. Gynecol Oncol. 2008;108:298-305.
11. Faratian D, Stillie A, Busby-Earle RM, et al. A review of the pathology and management of uterine papillary serous carcinoma and correlation with outcome. Int J Gynecol Cancer. 2006;16:972-978.
12. Barakat RR, Lev G, Hummer AJ, et al. Twelve-year experience in the management of endometrial cancer: a change in surgical and postoperative radiation approaches. Gynecol Oncol. 2007;105:150-156.
13. Rose P. Endometrial carcinoma. Review. NEJM. 1996;335:640-649.
14. Jordan LB, Abdul-Kader M, Al-Nafussi A. Uterine serous papillary carcinoma: histopathologic changes within the female genital tract. Int J Gynecol Cancer. 2001;11:283-289.
15. Grice J, Ek M, Greer B, et al. Uterine papillary serous carcinoma: evaluation of long-term survival in surgically staged patients. Gynecol Oncol. 1998;69:69-73.
16. Chan JK, Manuel MR, Cheung MK, et al. Breast cancer followed by corpus cancer: is there a higher risk for aggressive histological subtypes? Gynecol Oncol. 2006;102:508-512.
17. Gehrig PA, Bae-Jump VL, Boggess JF, et al. Association between uterine serous carcinoma and breast cancer. Gynecol Oncol. 2004;94:208-211.
18. Goshen R, Chu W, Elit L, et al. Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome? Gynecol Oncol. 2000;79:477-481.
19. Biron-Shental T, Drucker L, Altaras M, et al. High incidence of BRCA 1-2 germline mutations, previous breast cancer and familiar cancer history in Jewish patients with uterine serous papillary carcinoma. Eur J Surg Oncol. 2006;32:1097-1100.
20. Lavie O, Hornreich G, Ben-Arie A, et al. BRCA germline mutations in Jewish women with uterine serous papillary carcinoma. Gynecol Oncol. 2004;92:521-524.
21. Tseng PC, Sprance HE, Carcangiu ML, et al. CA 125, NB/70K and lipid-associated sialic acid in monitoring uterine papillary serous carcinoma. Obstet Gynecol. 1989;74:384-387.
22. Low JSH, Wong EH, Khoo Tan HS, et al. Adjuvant sequential chemotherapy and radiotherapy in uterine papillary serous carcinoma. Gynecol Oncol. 2005;97:171-177.
23. Schwartz PE. The management of serous papillary uterine cancer. Curr Opin Oncol. 2006;18:494-499.
24. Chan JK, Loizzi V, Youssef M, et al. Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium. Gyn Oncol. 2003;90:181-185.
25. Kelly MG, O'Malley DM, Hui P, et al. Improved survival in surgical stage I patients with uterine papillary serous carcinoma treated with adjuvant platinum-based chemotherapy. Gynecol Oncol. 2005;98: 353-359.
26. Havrilesky LJ, Alvarez Secord A, Bae-Jump V, et al. Outcomes in surgical stage I uterine papillary serous carcinoma. Gynecol Oncol. 2007;105:677-682.
27. Thomas MB, Mariani A, Cliby WA, et al. Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma. Gynecol Oncol. 2007;107:186-1889.